CompletedPhase 4

Culprit Lesion Only PCI Versus Multivessel PCI in Cardiogenic Shock

Germany706 participantsStarted 2013-04

Plain-language summary

The study compares the therapies of instant multivessel balloon angioplasty plus stent implantation or the balloon angioplasty plus stent implantation of the infarct artery alone with any possible graduated later treatment of the other vessels in patients with acute myocardial infarction with cardioganic shock. The main study hypothesis is to explore if culprit vessel only PCI with potentially subsequent staged revascularization in comparison to immediate multivessel revascularization by PCI in patients with cardiogenic shock complicating acute myocardial infarction reduces the incidence of 30- day mortality and/or severe renal failure requiring renal replacement therapy.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Systolic blood pressure less than 90 mmHg for more than 30 min or
✓. catecholamines required to maintain pressure more than 90 mmHg during systole and IV) Signs of pulmonary congestion V) Signs of impaired organ perfusion with at least one of the following criteria

What they're measuring

30-day mortality and/or severe renal failure requiring renal replacement therapy

Timeframe: 30 days

Trial details

NCT IDNCT01927549

SponsorUniversity of Luebeck

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-07

View on ClinicalTrials.gov More Cardiogenic Shock trials